NCT03039309 Endoscopic Submucosal Dissection for Early GI Neoplasia in the United Kingdom
| NCT ID | NCT03039309 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Portsmouth Hospitals NHS Trust |
| Condition | Endoscopic Submucosal Dissection |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2016-08-05 |
| Primary Completion | 2026-08-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2016-08-05 with a primary completion date of 2026-08-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Multicentre cohort study on the use of endoscopic submucosal dissection for the treatment of early gastrointestinal neoplasia.
Eligibility Criteria
Inclusion Criteria: * Male or Female, aged 18 years or above undergoing endoscopic submucosal dissection * Participant is able to give informed consent for participation in the study Exclusion Criteria: * Patients under the age of 18 * Patients unable to give informed consent
Contact & Investigator
Prof Pradeep Bhandari, MBBS, MD
PRINCIPAL INVESTIGATOR
Portsmouth Hospitals NHS Trust
Frequently Asked Questions
Who can join the NCT03039309 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Endoscopic Submucosal Dissection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03039309 currently recruiting?
Yes, NCT03039309 is actively recruiting participants. Contact the research team at pradeep.bhandari@porthosp.nhs.uk for enrollment information.
Where is the NCT03039309 trial being conducted?
This trial is being conducted at Portsmouth, United Kingdom.
Who is sponsoring the NCT03039309 clinical trial?
NCT03039309 is sponsored by Portsmouth Hospitals NHS Trust. The principal investigator is Prof Pradeep Bhandari, MBBS, MD at Portsmouth Hospitals NHS Trust. The trial plans to enroll 500 participants.